Status:
COMPLETED
Personal Patient Profile Prostate (P4) Randomized, Multisite Trial
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
University of Washington
Conditions:
Prostate Cancer
Eligibility:
MALE
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether or not participation in an experimental program called the "P4 program" is useful to men who are faced with choices about treatment for their early st...
Eligibility Criteria
Inclusion
- Biopsy-proven diagnosis of prostate cancer, stage I or II
- Diagnosis within the past 6 months
- Has appointment with a consulting specialist at one of the clinical trial sites
- Must be able to read and write English or Spanish at a 6th grade level
- Must not have begun any treatment (except watchful waiting)
- Must be able to complete baseline assessment before target clinician visit.
Exclusion
- Advanced prostate cancer
- Diagnosed more than 6 months ago
- Cannot read and write English or Spanish at a 6th grade level
- Does not have appointment at one of the clinical trial sites
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
498 Patients enrolled
Trial Details
Trial ID
NCT00692653
Start Date
February 1 2007
End Date
December 1 2009
Last Update
May 4 2015
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Medical Center / Medical College of Georgia
Augusta, Georgia, United States, 30904
2
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111
3
University of Texas Health Sciences Center at San Antonio
San Antonio, Texas, United States, 78229
4
Seattle Prostate Institute
Seattle, Washington, United States, 98104